Microdosing Semaglutide

Take an individualized approach to Semaglutide with a lower-dose starting strategy.

How it is intended to help: Semaglutide activates GLP-1 receptors involved in appetite and food intake. Weight-management regimens use a studied titration schedule and target dose for eligible patients. Microdosing uses lower or nonstandard doses.

What to expect: Lower dosing may be chosen to assess tolerability, but it does not guarantee fewer side effects or meaningful weight loss. Nausea, vomiting, diarrhea, constipation, and abdominal pain can occur. A clinician must review pregnancy, pancreatitis, gallbladder disease, diabetes medicines, kidney risk, severe stomach-emptying problems, and thyroid-cancer/MEN 2 history. Follow dose units exactly.